TetraLogic Pharmaceuticals Priced, Nasdaq: TLOG
Developing small molecule therapeutics for the treatment of cancer.
Industry: Health Care
First Day Return: 0.0%
Industry: Health Care
TLOG
Developing small molecule therapeutics for the treatment of cancer.
| IPO Data | |
|---|---|
| IPO File Date | 10/18/2013 |
| Offer Price | $7.00 |
| Price Range $7.00 - $7.00 | |
| Offer Shares (mm) | 7.2 |
| Deal Size ($mm) | $50 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 12/11/2013 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $50 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Malvern, PA, United States |
| Founded | 2001 |
| Employees at IPO | 20 |
| Website www.tetralogicpharma.com | |
IPO News for TetraLogic Pharmaceuticals
TetraLogic Pharmaceuticals (TLOG) Performance
